STOCK TITAN

[Form 4] GoodRx Holdings, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GoodRx Holdings, Inc. officer Christopher A. McGinnis exercised 36,987 restricted stock units into Class A common stock and received the same number of shares at no cash cost. Of these, 10,745 shares were withheld at $2.23 per share to cover tax obligations, leaving 152,563 Class A shares held directly. Following the transaction, 406,865 restricted stock units remained outstanding, which vest in 12 equal quarterly installments starting on April 15, 2026, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider McGinnis Christopher A
Role See Remarks
Type Security Shares Price Value
Exercise Restricted Stock Unit 36,987 $0.00 --
Grant/Award Class A Common Stock 36,987 $0.00 --
Tax Withholding Class A Common Stock 10,745 $2.23 $24K
Holdings After Transaction: Restricted Stock Unit — 406,865 shares (Direct); Class A Common Stock — 163,308 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.
RSUs exercised 36,987 units Restricted stock units converted into Class A common on April 15, 2026
Shares granted 36,987 shares Class A common stock received at $0.00 per share
Tax-withheld shares 10,745 shares Withheld at $2.23 per share to cover tax liabilities
Shares held after 152,563 shares Direct Class A common stock holdings after transactions
RSUs outstanding 406,865 units Restricted stock units remaining after this vesting event
Vesting schedule 12 quarterly installments RSUs vest ratably starting April 15, 2026, with continued service
RSU conversion ratio 1:1 Each restricted stock unit equals one Class A common share
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vest ratably financial
"The restricted stock units will vest ratably in 12 equal quarterly installments."
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGinnis Christopher A

(Last)(First)(Middle)
C/O GOODRX HOLDINGS, INC.
2701 OLYMPIC BOULEVARD

(Street)
SANTA MONICA CALIFORNIA 90404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/15/2026A36,987A(1)163,308D
Class A Common Stock04/15/2026F10,745D$2.23152,563D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)04/15/2026M36,987 (2) (2)Class A Common Stock36,987$0406,865D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2. The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.
Remarks:
Chief Financial Officer & Treasurer
/s/ Gracye Cheng, Attorney-in-Fact for Christopher A McGinnis04/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GoodRx (GDRX) report for Christopher A. McGinnis?

GoodRx reported that officer Christopher A. McGinnis exercised 36,987 restricted stock units into Class A common stock and received 36,987 shares. A portion of these shares was then withheld to satisfy tax obligations, reflecting a compensation-related equity vesting rather than an open-market trade.

How many GoodRx (GDRX) shares were withheld for taxes in this Form 4?

In this filing, 10,745 shares of GoodRx Class A common stock were withheld at $2.23 per share to cover tax liabilities. This tax-withholding disposition is a standard mechanism tied to equity vesting and does not represent an open-market sale by the officer.

How many GoodRx (GDRX) shares does Christopher A. McGinnis hold after the transaction?

After the reported transactions, Christopher A. McGinnis directly holds 152,563 shares of GoodRx Class A common stock. This figure reflects the net position after receiving 36,987 vested shares and having 10,745 shares withheld to satisfy associated tax obligations on the award.

What is the status of Christopher A. McGinnis’s remaining GoodRx (GDRX) restricted stock units?

Following the latest vesting, 406,865 restricted stock units remain outstanding for Christopher A. McGinnis. These RSUs are scheduled to vest in 12 equal quarterly installments beginning April 15, 2026, contingent on his continued service to GoodRx through each vesting date.

How do the GoodRx (GDRX) restricted stock units convert into shares for Christopher A. McGinnis?

Each GoodRx restricted stock unit represents a contingent right to receive one share of Class A common stock. As installments vest over time, the RSUs convert into shares, subject to continued service conditions, with some shares typically withheld to satisfy related tax liabilities.